Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
entara bio的股票交易上涨,因为公司宣布的结果显示在肥胖和代谢紊乱研究中具有显着的全身暴露和良好的PK特性。
Entera Bio Shares Are Trading Higher After the Company Announced Results Showing Significant Systemic Exposure and a Favorable PK Profile in Its Obesity and Metabolic Disorder Studies.
entrea bio股价上涨,因公司宣布结果显示在肥胖和代谢紊乱研究中出现显著全身曝露和有利的pk特性。